$Madrigal Pharmaceuticals (MDGL.US)$rose some 15% Tuesday after Wolfe Research reportedly initiated coverage of the pharma firm with a "Outperform" rating. MDGL gained as much as 15.2% to a $294.44 intraday high after Wolfe lauded the company's breakthrough liver drug Rezdiffra, according to published reports. The U.S. Food and Drug Administration approved Rezdiffra in March as the first treatment fornonalcoholic steatoh...
Market Maverick77 : 您从ATHA看到了什么?
George Soros II Market Maverick77 : 正如他所提到的,飞凡的数量
Market Maverick77 George Soros II : 好消息?
Stock_Drift 楼主 Market Maverick77 : 我看到它突破了0.54的支撑位。
yesyesyes : $Trio Petroleum (TPET.US)$
查看更多评论...